Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies. | Biomedicines | 2021 | 34069072 | PubTator, text mining | PubMed |
| From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies. | Biomedicines | 2021 | 34068948 | PubTator, text mining | PubMed |
| Cas12a and Lateral Flow Strip-Based Test for Rapid and Ultrasensitive Detection of Spinal Muscular Atrophy. | Biosensors (Basel) | 2021 | 34068874 | PubTator, text mining | PubMed |
| Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress. | Int J Mol Sci | 2021 | 34068052 | PubTator, text mining | PubMed |
| Synthesis and Anticancer Evaluation of New 1,3,4-Oxadiazole Derivatives. | Pharmaceuticals (Basel) | 2021 | 34066442 | PubTator, text mining | PubMed |
| Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities. | Int J Mol Sci | 2021 | 34065983 | PubTator, text mining | PubMed |
| Human-Specific Genes, Cortical Progenitor Cells, and Microcephaly. | Cells | 2021 | 34063381 | PubTator, text mining | PubMed |
| Towards population-scale long-read sequencing. | Nat Rev Genet | 2021 | 34050336 | PubTator, text mining | PubMed |
| SMA Identified: Clinical and Molecular Findings From a Sponsored Testing Program for Spinal Muscular Atrophy in More Than 2,000 Individuals. | Front Neurol | 2021 | 34025568 | PubTator, text mining | PubMed |
| Plastin 3 in health and disease: a matter of balance. | Cell Mol Life Sci | 2021 | 34023917 | PubTator, text mining | PubMed |
| Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies. | Transl Neurodegener | 2021 | 34016162 | PubTator, text mining | PubMed |
| The potential role of miRNA therapies in spinal muscle atrophy. | J Neurol Sci | 2021 | 34015517 | PubTator, text mining | PubMed |
| ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion. | Nucleic Acids Res | 2021 | 34009296 | PubTator, text mining | PubMed |
| One in seven pathogenic variants can be challenging to detect by NGS: an analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation. | Genet Med | 2021 | 34007000 | PubTator, text mining | PubMed |
| Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA). | BMC Pediatr | 2021 | 34001052 | PubTator, text mining | PubMed |
| Ultrastructural characterization of peripheral denervation in a mouse model of Type III spinal muscular atrophy. | J Neural Transm (Vienna) | 2021 | 33999256 | PubTator, text mining | PubMed |
| Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy. | JAMA Neurol | 2021 | 33999158 | PubTator, text mining | PubMed |
| Spinal Muscular Atrophy: The Use of Functional Motor Scales in the Era of Disease-Modifying Treatment. | Child Neurol Open | 2021 | 33997096 | PubTator, text mining | PubMed |
| Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent Developments. | Front Mol Biosci | 2021 | 33996898 | PubTator, text mining | PubMed |
| Splicing factor SRSF2-centric gene regulation. | Int J Biol Sci | 2021 | 33994855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=64